¾È¸é ½Å°æ¸¶ºñ ½ÃÀå : Áø´Üº°, Ä¡·áº°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø(2024-2032³â)
Facial Palsy Market, By Diagnosis, By Treatment, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1454116
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 298 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,539,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,495,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,892,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¾È¸é ½Å°æ¸¶ºñ ½ÃÀå ±Ô¸ð´Â 2023³â 32¾ï 2,100¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024-2032³â°£ ¿¬Æò±Õ 4.5% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾È¸é ½Å°æ¸¶ºñ ½ÃÀå - ½ÃÀå ¿ªÇÐ

¾È¸é ½Å°æ¸¶ºñ À¯º´·ü Áõ°¡·Î ½ÃÀå ¼ö¿ä ÃËÁø

¾È¸é ½Å°æ¸¶ºñÀÇ À¯º´·ü Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, º§ ¸¶ºñ´Â ¾È¸é ½Å°æ¸¶ºñÀÇ °¡Àå ÈçÇÑ ¿øÀÎÀÔ´Ï´Ù. ¾à 40,000¸íÀÇ ¹Ì±¹ÀÎÀÌ º§ ¸¶ºñ·Î ÀÎÇÑ ¾È¸é ½Å°æ¸¶ºñ¸¦ ¾Î°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ³úÁ¹ÁßÀ¸·Î ÀÎÇÑ ¾È¸é ½Å°æ¸¶ºñ´Â ¾ó±¼ ±ÙÀ°À» Áö¹èÇÏ´Â ½Å°æÀ» ¼Õ»ó½Ãŵ´Ï´Ù. ³úÁ¹ÁßÀº ÃâÇ÷À» ÀÏÀ¸ÄÑ »ê¼Ò¸¦ »©¾Ñ¾Æ ³ú Á¶Á÷À» ¼Õ»ó½Ãŵ´Ï´Ù. ¾È¸é ½Å°æ¸¶ºñÀÇ ´Ù¸¥ ¿øÀÎÀ¸·Î´Â ¸áÄ¿½¼-·ÎÁ¨Å» ÁõÈıº, ±æ¶û-¹Ù·¹ ÁõÈıº, ¸Þºñ¿ì½º ÁõÈıº, ¶óÀÓº´, ·¥Áö-Ç寮 ÁõÈıº µîÀÌ ÀÖ½À´Ï´Ù. º§ ¸¶ºñ ȯÀÚ´Â 15¼¼¿¡¼­ 60¼¼ »çÀÌ¿¡ ¸¹ÀÌ ¹ß»ýÇÕ´Ï´Ù.

¾È¸é ½Å°æ¸¶ºñ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ® ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 4.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áø´Ü ¼¼ºÐÈ­¸¦ ±âÁØÀ¸·Î º¼ ¶§, MRI ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ä¡·á ¼¼ºÐÈ­¸¦ ±âÁØÀ¸·Î ºñ¼ö¼úÀû ¼¼ºÐÈ­°¡ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃÖÁ¾ ¿ëµµ ¼¼ºÐÈ­¸¦ ±âÁØÀ¸·Î º¼ ¶§, º´¿ø ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾È¸é ½Å°æ¸¶ºñ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è ¾È¸é ½Å°æ¸¶ºñ ½ÃÀåÀº Áø´Ü, Ä¡·á, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

Áø´Ü¿¡ µû¶ó ½ÃÀåÀº MRI, CT, ±ÙÀüµµ(EMG)·Î ºÐ·ùµÇ¸ç, MRI ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾È¸é ½Å°æ¸¶ºñ°¡ µÎÅë, Çö±âÁõ, ½Ã°¢ ¹× û°¢ º¯È­¿Í °°Àº ´Ù¸¥ ½Å°æ Áõ»óÀ» µ¿¹ÝÇÏ´Â °æ¿ì, MRI´Â ½Å°æ°è¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ±âÀú ÁúȯÀ» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

Ä¡·á ¹æ¹ý¿¡ µû¶ó ½ÃÀåÀº ¼ö¼úÀû Ä¡·á¿Í ºñ¼ö¼úÀû Ä¡·á·Î ³ª´µ¸ç, 2023³â¿¡´Â ºñ¼ö¼úÀû Ä¡·á°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È¿¡µµ µ¿ÀÏÇÑ ÆÐÅÏÀÌ Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹°¸®Ä¡·á´Â ¾È¸é ±ÙÀ°À» °­È­Çϰí, ÇùÀÀ·ÂÀ» Çâ»ó½Ã۸ç, ¿îµ¿ ¹üÀ§¸¦ ȸº¹ÇÏ´Â ¿îµ¿°ú ±â¼ú¿¡ ÁßÁ¡À» µÎ¾î ¾È¸é ½Å°æ¸¶ºñ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¾È¸é ¿îµ¿, ¸¶»çÁö, Àü±â ÀÚ±Ø, ¹ÙÀÌ¿ÀÇǵå¹é µîÀÇ Ä¡·á¹ýÀÌ È¸º¹À» ÃËÁøÇϱâ À§ÇØ ÀϹÝÀûÀ¸·Î äÅõǰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ¾÷°è´Â º´¿ø°ú Àü¹®¼¾ÅÍ·Î ³ª´¹´Ï´Ù. º´¿ø ½ÃÀåÀº ȯÀÚ ¼ö°¡ ¸¹°í ÷´Ü ±â¼úÀÇ Á¸Àç·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾È¸é ½Å°æ¸¶ºñ ½ÃÀå - Áö¸®Àû ÅëÂû·Â

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«À¸·Î ³ª´¹´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á® ¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù. ºÏ¹Ì´Â ¿¹Ãø ±â°£ µ¿¾È ¾È¸é ½Å°æ¸¶ºñ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾È¸é ½Å°æ¸¶ºñ °ü¸®¸¦ Áö¿øÇÏ´Â Àü¹® Ŭ¸®´Ð°ú ÀçȰ ÇÁ·Î±×·¥ µî Àß È®¸³µÈ ÀÇ·á ½Ã¼³Àº ºÏ¹Ì Àü¿ª¿¡ °ÉÃÄ ÀÖÁö¸¸, ƯÈ÷ ¹Ì±¹°ú ij³ª´Ù¿¡ ÁýÁߵǾî ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ÀÇ·áºñ Áõ°¡, Èñ±ÍÁúȯ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °³¼± µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¬±¸±â°ü, Á¦¾àȸ»ç, ÀÇ·á±â°üÀÇ Çù·ÂÀº ÀÌ Áö¿ª¿¡¼­ »õ·Î¿î ¾È¸é ½Å°æ¸¶ºñ Ä¡·á¹ýÀ» °³¹ßÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

¾È¸é ½Å°æ¸¶ºñ ½ÃÀå - °æÀï »óȲ:

ÀÌ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Boston Scientific Corporation, Novartis AG, Cyberonics, Inc, Astellas Pharma Inc, Mallinckrodt, Cerebomed, BioControl, Inc. Medical, Sucampo Pharmaceuticals µîÀÌ ÀÖ½À´Ï´Ù. »õ·Î¿î ½ÃÀå¿¡ Á¢±ÙÇϱâ À§ÇØ ½ÃÀå ÁøÃâ±â¾÷µéÀº ½ÅÁ¦Ç° °³¹ß, ÀÚ±Ý Á¶´Þ ¹× ÅõÀÚ, ÀμöÇÕº´(M&A), ±âŸ Àü·«Àû Á¦ÈÞ µî ´Ù¾çÇÑ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ Áö¼ÓÀûÀ¸·Î ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¾È¸é ½Å°æ¸¶ºñ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾È¸é ½Å°æ¸¶ºñ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¾È¸é ½Å°æ¸¶ºñ ¾÷°è Á¶»ç

Á¦5Àå ¾È¸é ½Å°æ¸¶ºñ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ¾È¸é ½Å°æ¸¶ºñ ½ÃÀå ±¸µµ

Á¦7Àå ¾È¸é ½Å°æ¸¶ºñ ½ÃÀå - Áø´Üº°

Á¦8Àå ¾È¸é ½Å°æ¸¶ºñ ½ÃÀå - Ä¡·áº°

Á¦9Àå ¾È¸é ½Å°æ¸¶ºñ ½ÃÀå - ÃÖÁ¾ ¿ëµµº°

Á¦10Àå ¾È¸é ½Å°æ¸¶ºñ ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¾È¸é ½Å°æ¸¶ºñ ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Facial Palsy Market size was valued at USD 3,221 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

Facial palsy is a broad term for paralysis of the face muscles, primarily due to acute or chronic injury to the face nerve. The facial muscles cannot contract correctly if a facial nerve is absent or non-functioning. This is because the muscles need to receive impulses in order to contract. This causes the afflicted facial area to become paralyzed, which can impair mobility in other regions of the face as well as the affected eye or mouth.

Facial Palsy Market- Market Dynamics

Growing prevalence of facial paralysis to propel market demand

The growing prevalence of facial paralysis is expected to propel the market growth during the forecast period. For instance, Bell's palsy is the most prevalent cause of facial paralysis, according to the National Institute of Neurological Disorders and Stroke. An estimated 40,000 Americans are thought to suffer from facial paralysis brought on by Bell's palsy. Stroke-related facial paralysis damages the nerves that govern the face muscles. Stoke results in bleeding and damages brain tissue by depriving it of oxygen. Additional causes of facial paralysis include Melkersson-Rosenthal syndrome, Guillain-Barre syndrome, Mobius syndrome, Lyme illness, and Ramsay-Hunt syndrome. People with Bell's palsy are more likely to be between the ages of 15 and 60.

Facial Palsy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on diagnosis segmentation, the MRI segment is expected to capture a significant market share during the forecast period

Based on the treatment segmentation, the non-surgical segment held the largest market share in 2023

Based on end-use segmentation, the hospitals segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

Facial Palsy Market- Segmentation Analysis:

The Global Facial Palsy Market is segmented based on Diagnosis, Treatment, End-use, and Region.

Based on the diagnosis, the market is categorized into MRI, CT and Electromyograph (EMG). The MRI segment is expected to capture a significant market share during the forecast period. When facial palsy is accompanied by other neurological symptoms, such as headaches, dizziness, or changes in vision or hearing, MRI can help identify any underlying conditions affecting the nervous system.

Based on the treatment, the market is divided into Surgical and Non-Surgical. The non-surgical held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. Physical therapy plays a crucial role in the management of facial palsy by focusing on exercises and techniques to strengthen facial muscles, improve coordination, and restore range of motion. Therapeutic modalities such as facial exercises, massage, electrical stimulation, and biofeedback are commonly employed to facilitate recovery. Thereby, driving the segment growth.

Based on the end-use, the industry is divided into Hospitals and Specialty Centers. The hospitals segment is expected to lead the market over the projected period owing to large pool of patients and the presence of advanced technologies.

Facial Palsy Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the Facial Palsy market during the forecast period. Well-established healthcare facilities, including specialist clinics and rehabilitation programs that aid in the management of facial palsy, may be found across North America, but especially in the United States and Canada. Due to factors including growing healthcare expenses, growing awareness of rare diseases, and developing healthcare infrastructure, the market is anticipated to grow considerably in Asia Pacific. Research institutes, pharmaceutical businesses, and healthcare organizations working together might result in the creation of novel facial palsy therapies in the area.

Facial Palsy Market- Competitive Landscape:

The key players operating in the market are Boston Scientific Corporation, Novartis AG, Cyberonics, Inc., Astellas Pharma Inc., Mallinckrodt, Cerebomed, BioControl Medical and Sucampo Pharmaceuticals. To obtain access to new markets, market players are continuously pursuing a variety of strategic initiatives, including the creation of new products, funding and investments, mergers and acquisitions, and other strategic partnerships.

Recent Developments:

In July 2023, a state-of-the-art Facial Palsy Care Center including cutting-edge technology and a skilled group of exceptionally skilled surgeons was opened by Sakra World Hospital. By combining cutting-edge technology with a skilled multidisciplinary team of surgeons and other healthcare professionals, the center sought to transform treatment models, improve overall therapeutic results, and significantly improve the quality of life for those with facial palsy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FACIAL PALSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Boston Scientific Corporation

Novartis AG

Cyberonics, Inc.

Astellas Pharma Inc.

Mallinckrodt

Cerebomed

BioControl Medical

Sucampo Pharmaceuticals

GLOBAL FACIAL PALSY MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

GLOBAL FACIAL PALSY MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

GLOBAL FACIAL PALSY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

GLOBAL FACIAL PALSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1.Facial Palsy Market Overview

2.Executive Summary

3.Facial Palsy Key Market Trends

4.Facial Palsy Industry Study

5.Facial Palsy Market: COVID-19 Impact Analysis

6.Facial Palsy Market Landscape

7.Facial Palsy Market - By Diagnosis

8.Facial Palsy Market - By Treatment

9.Facial Palsy Market - By End-use

10.Facial Palsy Market- By Geography

11.Key Vendor Analysis- Facial Palsy Industry

12.360 Degree Analyst View

13.Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â